{"id":229762,"date":"2020-05-08T00:00:00","date_gmt":"2020-05-08T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/m360pv0064-medtech-peripheral-vascular-devices-market-insights-2\/"},"modified":"2026-04-14T10:06:01","modified_gmt":"2026-04-14T10:06:01","slug":"m360pv0064-medtech-peripheral-vascular-devices-market-insights-canada","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/m360pv0064-medtech-peripheral-vascular-devices-market-insights-canada\/","title":{"rendered":"Peripheral Vascular Devices &#8211; Market Insights &#8211; Canada"},"content":{"rendered":"<p>\n\tThe Canadian market for\u00a0<abbr title=\"Peripheral Vascular\">PV<\/abbr>\u00a0devices is an evolving market in which an underdiagnosed and underserved patient population and innovative product launches will facilitate significant procedure volume expansion. However, cost constraints in the publicly funded health care system continue to hinder penetration of endovascular treatment; as a result, the Canadian <abbr title=\"Peripheral Vascular\">PV<\/abbr> device market will grow modestly through 2028, despite rising <abbr title=\"Peripheral Vascular Disease\">PVD<\/abbr> diagnosis rates.<\/p>\n<p>\n\tThis Medtech 360 Report provides comprehensive data and analysis on the current state of the market for <abbr title=\"Peripheral Vascular\">PV<\/abbr> devices\u00a0in Canada\u00a0across a 10-year period.<\/p>\n<p class=\"question-statement\">\n\t<b>The publication of the Katsanos study in late 2018 and its fallout had a significant impact on the\u00a0<abbr title=\"Drug-Coated Balloon\">DCB<\/abbr>\u00a0market in 2019.<\/b><\/p>\n<p>\n\tWhat effect did data highlighting safety concerns with paclitaxel-coated devices have on the\u00a0<abbr title=\"Drug-Coated Balloon\">DCB<\/abbr>\u00a0market?<\/p>\n<p>\n\tTo what degree was\u00a0<abbr title=\"Drug-Coated Balloon\">DCB<\/abbr>s\u00a0 adoption in Canada curtailed over the forecast period?<\/p>\n<p>\n\tHow many competitors will enter the\u00a0<abbr title=\"Drug-Coated Balloon\">DCB<\/abbr>\u00a0market?<\/p>\n<p class=\"question-statement\">\n\t<strong>The <abbr title=\"Coronavirus Disease 2019\">COVID-19<\/abbr> pandemic in early 2020 will cause a moderate decline in overall\u00a0<abbr title=\"Peripheral Vascular\">PV<\/abbr> procedures and revenues in 2020.<\/strong><\/p>\n<p>\n\tWhat factors contribute to the market decline?<\/p>\n<p>\n\tTo what degree will the pandemic affect different\u00a0<abbr title=\"Peripheral Vascular\">PV<\/abbr>\u00a0device segments?<\/p>\n<p>\n\tHow soon will procedure volumes, sales, and revenues recover over the forecast period?<\/p>\n<p class=\"question-statement\">\n\t<b>Endovascular\u00a0<abbr title=\"Peripheral Vascular\">PV<\/abbr>\u00a0adoption in Canada is significantly behind other developed health care markets, such as the US and Europe.<\/b><\/p>\n<p>\n\tWhat factors contribute to this delay in adoption?<\/p>\n<p>\n\tWill the uptake of endovascular techniques improve in Canada in the future?<\/p>\n<p>\n\tWhat strategies can manufacturers implement to boost\u00a0<abbr title=\"Peripheral Vascular\">PV<\/abbr>\u00a0device use in Canada?<\/p>\n<p class=\"question-statement\">\n\t<b>Manufacturers in Canada compete for hospital tender contracts.<\/b><\/p>\n<p>\n\tHow has this practice affected the Canadian\u00a0<abbr title=\"Peripheral Vascular\">PV<\/abbr>\u00a0competitive landscape?<\/p>\n<p>\n\tTo what degree will price competition to win contracts affect the market overall?<\/p>\n","protected":false},"template":"","class_list":["post-229762","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-therapy-area-peripheral-vascular-devices","medtech-geography-canada","medtech-date-945"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/229762","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/229762\/revisions"}],"predecessor-version":[{"id":283172,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/229762\/revisions\/283172"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=229762"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}